ABBV
AbbVie, Inc. · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website abbvie.com
- Employees(FY) 50000
- ISIN US00287Y1091
Performance
+6.33%
1W
+4.64%
1M
+7.41%
3M
+25.27%
6M
+34.94%
YTD
+48.1%
1Y
Profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Technical Analysis of ABBV 2024-11-05
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-05 11:02
- 2024-11-05 09:00
- 2024-11-05 07:45
- 2024-11-05 06:00
Should We Be Delighted With AbbVie Inc.'s (NYSE:ABBV) ROE Of 75%?(Simply Wall St.)
- 2024-11-05 00:06
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight(GuruFocus.com)
- 2024-11-04 22:00
- 2024-11-04 18:05
- 2024-11-04 17:55
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy Right Now?(Insider Monkey)
- 2024-11-04 08:07
- 2024-11-04 07:25
Analyst Report: AbbVie Inc(Argus Research)
- 2024-11-04 07:10
Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLH(Argus Research)
- 2024-11-02 11:00
- 2024-11-01 15:07
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade(Investor's Business Daily)
- 2024-11-01 15:00
- 2024-11-01 11:57
- 2024-11-01 09:20
- 2024-11-01 07:46
AbbVie and EvolveImmune Therapeutics sign oncology collaboration(Pharmaceutical Technology)
- 2024-11-01 07:44
- 2024-11-01 06:06
- 2024-11-01 05:00
- 2024-10-31 17:00
- 2024-10-31 11:14
- 2024-10-31 11:10
- 2024-10-31 08:00
- 2024-10-31 07:46
- 2024-10-31 07:06
- 2024-10-31 07:00
- 2024-10-31 07:00
- 2024-10-31 07:00
- 2024-10-31 06:48
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.